TRIM6
Tripartite motif-containing protein 6
Also known as: RNF89, TRIM6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9C030
- Gene
- TRIM6
- Ensembl
- ENSG00000121236
- Chromosome
- 11
- Canonical length
- 488 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, B-box type 1 and B-box type 2 domain, and a coiled-coil region. The protein localizes to the nucleus, but its specific function has not been identified. This gene is mapped to chromosome 11p15, where it resides within a TRIM gene cluster. Alternative splicing results in multiple transcript variants. A read-through transcript from this gene into the downstream TRIM34 gene has also been observed, which results in a fusion product from these neighboring family members. [provided by RefSeq, Oct 2010]
Canonical amino-acid sequenceUniProt
488 residues, UniProt reviewed canonical sequence.
>Q9C030|TRIM6
1 MTSPVLVDIR EEVTCPICLE LLTEPLSIDC GHSFCQACIT PNGRESVIGQ EGERSCPVCQ
61 TSYQPGNLRP NRHLANIVRR LREVVLGPGK QLKAVLCADH GEKLQLFCQE DGKVICWLCE
121 RSQEHRGHHT FLVEEVAQEY QEKFQESLKK LKNEEQEAEK LTAFIREKKT SWKNQMEPER
181 CRIQTEFNQL RNILDRVEQR ELKKLEQEEK KGLRIIEEAE NDLVHQTQSL RELISDLERR
241 CQGSTMELLQ DVSDVTERSE FWTLRKPEAL PTKLRSMFRA PDLKRMLRVC RELTDVQSYW
301 VDVTLNPHTA NLNLVLAKNR RQVRFVGAKV SGPSCLEKHY DCSVLGSQHF SSGKHYWEVD
361 VAKKTAWILG VCSNSLGPTF SFNHFAQNHS AYSRYQPQSG YWVIGLQHNH EYRAYEDSSP
421 SLLLSMTVPP RRVGVFLDYE AGTVSFYNVT NHGFPIYTFS KYYFPTTLCP YFNPCNCVIP
481 MTLRRPSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRIM6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- kidney: 20 nTPM
- salivary gland: 9.9 nTPM
- testis: 8.7 nTPM
- placenta: 5 nTPM
- smooth muscle: 4.9 nTPM
- epididymis: 4.6 nTPM
Single-cell type
- microglia: 3.5 nCPM
- epicardial cells: 2.3 nCPM
- ependymal cells: 1.6 nCPM
- late primary spermatocytes: 1.3 nCPM
- astrocytes: 1.2 nCPM
- brain excitatory neurons: 0.6 nCPM
Immune cell
- neutrophil: 1.2 nTPM
- myeloid DC: 0.7 nTPM
- eosinophil: 0.4 nTPM
- NK-cell: 0.3 nTPM
- basophil: 0.2 nTPM
- plasmacytoid DC: 0.2 nTPM
Brain region
- medulla oblongata: 2.8 nTPM
- choroid plexus: 2.4 nTPM
- thalamus: 2.4 nTPM
- hypothalamus: 2.2 nTPM
- midbrain: 2.2 nTPM
- spinal cord: 2.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.11
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.02
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antiviral innate immune response
- cellular response to interferon-beta
- cellular response to virus
- free ubiquitin chain polymerization
- innate immune response
- negative regulation of DNA-templated transcription
- negative regulation of gene expression
- negative regulation of stem cell differentiation
- negative regulation of viral genome replication
- positive regulation of cytokine production involved in immune response
- positive regulation of defense response to virus by host
- positive regulation of peptidyl-serine phosphorylation
- positive regulation of peptidyl-threonine phosphorylation
- positive regulation of transcription regulatory region DNA binding
- positive regulation of type I interferon-mediated signaling pathway
- protein K48-linked ubiquitination
- regulation of gene expression
- response to lipopolysaccharide
Molecular functions
- DNA-binding transcription factor binding
- identical protein binding
- protein kinase binding
- protein tyrosine kinase binding
- protein-macromolecule adaptor activity
- ubiquitin protein ligase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- B-box-type zinc finger
- Zinc finger, RING-type
- B30.2/SPRY domain
- SPRY domain
- Butyrophylin-like, SPRY domain
- SPRY-associated
- Zinc finger, RING/FYVE/PHD-type
- Concanavalin A-like lectin/glucanase domain superfamily
- Zinc finger, RING-type, conserved site
- Zinc finger, RING-type, eukaryotic
- B30.2/SPRY domain superfamily
- Tripartite motif-containing
- SPRY domain
- B-box zinc finger
- RING-type zinc-finger
- TRIM6, PRY/SPRY domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRIM6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRIM6 as an antibody target. Whether an autoantibody or antibody against TRIM6 could matter depends on whether native TRIM6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRIM6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRIM6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...